Vascular parkinsonism - An important update

Age and Ageing

Volumn 34, Issue 2, 2005, Pages 97-98

  Turnbull, Chris ^a  

^a ARROWE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CARDIOLIPIN ANTIBODY; LEVODOPA;

ATHEROSCLEROSIS; BODY POSTURE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; EDITORIAL; ESSENTIAL TREMOR; FREQUENCY ANALYSIS; GAIT DISORDER; HUMAN; IDIOPATHIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SMELLING;

ANTIPARKINSON AGENTS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LEVODOPA; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; OLFACTION DISORDERS; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; SENSITIVITY AND SPECIFICITY;

EID: 14744306352     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afi048     Document Type: Editorial

References (16)

1. Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez JM, Porta-Etessam J, Trincado R, Vega S, Louis ED for the Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 2004; 9: 734-41.
2. Critchley M. Arteriosclerotic parkinsonism. Brain 1929; 52: 23-83.
3. Eadie MJ, Sutherland JM. Arteriosclerosis in Parkinsonism. J Neurol Neurosurg Psychiatry 1964; 27: 237-40.
4. Jellinger KA. The pathology of Parkinson's disease. Adv Neurol 2001; 86: 55-72.
5. Zijlmans JCM, Katzenschlager R, Daniel SE, Lees AJL The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 2004; 75: 545-7.
6. Thanvi B, Lo N, Robinson T. Vascular parkinsonism - an important cause of parkinsonism in older people. Age Ageing 2005; 34: 114-9.
7. Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson's disease in a Scottish city. BMJ 1986; 292: 534-6.
8. Quinn N. Parkinsonism - recognition and differential diagnosis. BMJ 1995; 310: 447-52.
9. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001; 104: 63-7.
10. Zijlmans JCM, Daniel SE, Hughes AJ, Révész T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004; 19: 630-40.
11. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989; 4: 249-60.
12. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999; 56: 98-102.
13. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1749-52.
14. Marshall V, Grossett D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 2003; 18: 1415-23.
15. Peralta C, Werner P, Holl B et al. Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort. J Neural Transm 2004; 111: 1473-83. Epub 2004 Aug 03.
16. Sibon I, Fenelon G, Quinn NP, Tison F. Vascular parkinsonism. J Neurol 2004; 251: 513-24.